Literature DB >> 26852846

Formulation and Evaluation of a Mucoadhesive Thermoresponsive System Containing Brazilian Green Propolis for the Treatment of Lesions Caused by Herpes Simplex Type I.

Renata Sespede Mazia1, Raphaela Regina de Araújo Pereira2, Lizziane Maria Belloto de Francisco1, Maria Raquel Marçal Natali3, Benedito Prado Dias Filho4, Celso Vataru Nakamura4, Marcos Luciano Bruschi5, Tânia Ueda-Nakamura6.   

Abstract

The aim of the present work was to develop a topical delivery system that contains Brazilian green propolis extract (PE-8) to increase efficiency and convenience when applied to herpetic lesions. The cytotoxicity and antiherpetic activity was determined in vitro and in vivo. The PE-8 was added to a system that contained poloxamer 407 and carbopol 934P. The in vitro characterization of the system included rheological studies, texture profile analysis, and mucoadhesion analysis. The PE-8 inhibited the virus during the phase of viral infection, induced virion damage, and exhibited an ability to protect cells from viral infection. The system had advantageous mucoadhesive properties, including a suitable gelation temperature of approximately 25°C for topical delivery, a desirable textural profile, and pseudoplastic behavior. The in vitro release study showed a rapid initial release of the PE-8 in the first 3 h, and the rate of drug release remained constant for up to 24 h. The system appeared to be macroscopically and microscopically innocuous to skin tissue. Therefore, the mucoadhesive thermoresponsive system that contained the PE-8 appears to be promising for increasing bioavailability and achieving prolonged release of the PE-8 when applied to skin lesions caused by herpes simplex virus type 1.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brazilian green propolis; herpes simplex type I; mucoadhesive; rheology; viscoelastic

Mesh:

Substances:

Year:  2016        PMID: 26852846     DOI: 10.1016/j.xphs.2015.11.016

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Antiviral activity of Brazilian Green Propolis extract against SARS-CoV-2 (Severe Acute Respiratory Syndrome - Coronavirus 2) infection: case report and review.

Authors:  Ana C Fiorini; Carla A Scorza; Antonio-Carlos G de Almeida; Marcelo C M Fonseca; Josef Finsterer; Fernando L A Fonseca; Fulvio A Scorza
Journal:  Clinics (Sao Paulo)       Date:  2021-01-22       Impact factor: 2.365

Review 2.  Propolis antiviral and immunomodulatory activity: a review and perspectives for COVID-19 treatment.

Authors:  Nicolas Ripari; Arthur Alves Sartori; Mariana da Silva Honorio; Fernanda Lopes Conte; Karen Ingrid Tasca; Karina Basso Santiago; José Maurício Sforcin
Journal:  J Pharm Pharmacol       Date:  2021-03-06       Impact factor: 3.765

Review 3.  New Insights into Potential Beneficial Effects of Bioactive Compounds of Bee Products in Boosting Immunity to Fight COVID-19 Pandemic: Focus on Zinc and Polyphenols.

Authors:  Meryem Bakour; Hassan Laaroussi; Driss Ousaaid; Asmae El Ghouizi; Imane Es-Safi; Hamza Mechchate; Badiaa Lyoussi
Journal:  Nutrients       Date:  2022-02-23       Impact factor: 5.717

Review 4.  Perspectives for Uses of Propolis in Therapy against Infectious Diseases.

Authors:  Antonio Salatino
Journal:  Molecules       Date:  2022-07-19       Impact factor: 4.927

5.  Evidence-Based Studies and Perspectives of the Use of Brazilian Green and Red Propolis in Dentistry.

Authors:  Claudemir de Carvalho; Wesley Henrique Cabral Fernandes; Thays Barreto Freitas Mouttinho; Daniela Martins de Souza; Maria Cristina Marcucci; Paulo Henrique Perlatti D'Alpino
Journal:  Eur J Dent       Date:  2019-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.